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Innate immunememory, or trained immunity, has recently been described to be an important property of cells of the innate im-
mune system. Due to the increased interest in this important new field of immunological investigation, we sought to determine
the optimal conditions for an in vitro experimental protocol of monocyte training using three of the most commonly used train-
ing stimuli from the literature:-glucan, the bacillus Calmette-Guérin (BCG) vaccine, and oxidized low-density lipoprotein (ox-
LDL). We investigated and optimized a protocol of monocyte trained immunity induced by an initial training period with -glu-
can, BCG, or oxLDL, followed by washing and resting of the cells and, thereafter, restimulation with secondary bacterial stimuli.
The training and resting time intervals were varied to identify the optimal setting for the long-term induction of trained immu-
nity. Trained immunity was assessed in terms of the secondary cytokine response, the production of reactive oxygen species, cell
morphology, and induction of glycolysis. Monocytes primed with -glucan, BCG, and oxLDL showed increased pro- and anti-
inflammatory cytokine responses upon restimulation with nonrelated stimuli. Also, all three stimuli induced a switch to glycoly-
sis (theWarburg effect). These effects were most pronounced when the training interval was 24 h and the resting time interval
was 6 days. Training with BCG and oxLDL also led to the increased production of reactive oxygen species, whereas training with
-glucan led to the decreased production of reactive oxygen species. We describe the optimal conditions for an in vitro experi-
mental model with human primary monocytes for study of the induction of trained innate immunity by microbial andmetabolic
stimuli.
The immune response is a complex system of cellular and hu-moral components which have the ability to detect non-self-
structures and confer protection against invading pathogens,
playing a crucial role in the survival of multicellular organisms.
The immune response has traditionally been divided into the in-
nate immune system and the adaptive immune system. Adaptive
immunity, with T and B cells as cellular effectors, develops over
several weeks after birth, is highly specific, and builds a specific
immunological memory, leading to protection against reinfec-
tion. The innate immune system, on the other hand, is classically
thought to act rapidly in a nonspecific and identical manner every
time that it encounters a pathogen, without having the ability to
build an immunological memory.
Recently, the concept that innate immunity is nonspecific and
completely lacks immunological memory has been challenged.
First, pattern recognition receptors (PRRs) confer some specific-
ity to innate immunity, and second, a growing body of literature
shows that innate immunity can adapt its function after a first
insult (1, 2). Several studies have shown that plants and inverte-
brates, organisms which lack an adaptive immune system, show
enhanced immune responses upon reinfection (3). This phenom-
enon has recently been confirmed in higher vertebrates and hu-
mans and has been named “trained immunity” or “innate im-
mune memory.” Trained immunity is dependent on epigenetic
remodeling and on rewiring of intracellular metabolic pathways,
which in turn lead to a long-term proinflammatory phenotype
that is characterized by increased cytokine responses (4, 5).
A series of recent in vitro and in vivo experiments has revealed
that the phenomenon of trained immunity is induced by both
pathogen-associated molecular patterns (PAMPs) and a number
of danger-associated molecular patterns (DAMPs). First, in mice,
a single dose of Candida albicans confers protection against rein-
fectionwith Staphylococcus aureus. In vitro studies showed that the
C. albicans cell wall component -glucan induces epigenetic re-
modeling and functional reprogramming through a dectin-1/
Raf1-dependent pathway (6, 7). Second, bacillus Calmette-
Guérin (BCG) vaccination of healthy human volunteers resulted
in the nonspecific upregulation of ex vivo cytokine production by
isolated monocytes that persisted for at least 3 months after vac-
cination. This effect is dependent on NOD2 signaling, autophagy,
and epigenetic changes in histone methylation leading to in-
creased transcription and likely explains, at least in part, the ob-
served nonspecific effects of BCG on overall mortality (8–10).
Third, the atherogenic lipid oxidized low-density lipoprotein (ox-
LDL) induces long-term proatherogenic changes in monocytes in
vitro leading to increased proatherogenic cytokine expression, in-
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creased scavenger receptor expression, decreased cholesterol ef-
flux transporter expression, and, ultimately, increased foam cell
formation. This effect is dependent on Toll-like receptor 4
(TLR4)/TLR2 and subsequent phosphatidylinositol 3-kinase and
extracellular signal-regulated kinase activation and epigenetic
changes in histone methylation (e.g., H3K4me3, H3K9me3, and
H3K27me3), resulting in increased transcription (11, 12).
In recent years, there has been an increased interest in immu-
nological research in the study of trained immunity, with studies
assessing different organisms and diseases (13–17) Therefore, we
sought to determine the optimal conditions for an in vitro exper-
imental protocol of monocyte training using three of the most
commonly used training stimuli from the literature: -glucan,
BCG vaccine, and oxLDL.
MATERIALS AND METHODS
Reagents.-1,3-(D)-Glucanwas kindly provided byDavidWilliams (TN,
USA), BCG (vaccine Statens Serum Institut) was obtained from The
Netherlands Vaccine Institute. oxLDL was prepared as described before
(18). Escherichia coli lipopolysaccharide (LPS; serotype O55:B5; Sigma-
Aldrich, St. Louis, MO, USA) was further purified as described previously
(19), and Pam3Cys was obtained from EMC Microcollections (catalog
number L2000). Luminol and zymosan (from Saccharomyces cerevisiae)
were purchased from Sigma-Aldrich.
PBMCandmonocyte isolation.Buffy coats fromhealthy donorswere
obtained after they provided written informed consent (Sanquin Blood
Bank, Nijmegen, The Netherlands). Isolation of peripheral blood mono-
nuclear cells (PBMCs) was performed by dilution of blood in sterile phos-
phate-buffered saline (PBS) and density centrifugation over Ficoll-Paque
(GE Healthcare, UK). Cells were washed three times in cold PBS. Percoll
isolation of monocytes was performed as described previously (20).
Briefly, 150 106 to 200 106 PBMCs were layered on top of a hyperos-
motic Percoll solution (48.5% Percoll [Sigma-Aldrich, St. Louis, MO,
USA], 41.5% sterile H2O, 0.16 M filter-sterilized NaCl) and centrifuged
for 15min at 580 g. The interphase layer was isolated, and the cells were
washed with cold PBS. Cells were resuspended in Dutch modified RPMI
culturemedium (Invitrogen, CA,USA) supplementedwith 10g/ml gen-
tamicin, 10 mMGlutaMAX, and 10 mM pyruvate and counted. An extra
purification step was added by allowing Percoll-isolated monocytes to
adhere to polystyrene flat-bottom plates (Corning, NY, USA) for 1 h at
37°C; the cells were washed with warm PBS to obtain maximal purity. At
this point, the level of T-cell contamination, which was measured by flu-
orescence-activated cell sorting, was 5% (see Fig. S1 in the supplemental
material).
Trained immunitymodel in humanmonocytes.Cells (100,000 cells/
well) were added to flat-bottom 96-well plates. After incubation for 1 h at
37°C and washing with warm PBS, monocytes were incubated with cul-
ture medium only as a negative control or 5 g/ml -glucan, 10 g/ml
BCG, or 10 g/ml oxLDL for 2, 4, or 24 h (in 200 l/well RPMI plus 10%
pooled human serum) (Fig. 1). After the incubation time indicated above,
the cells were washed once with 200l warm PBS and incubated for 24 h,
3 days, or 6 days in culturemediumwith 10% serum, and themediumwas
changed once at day 3 for cells resting for 6 days. Cells were restimulated
with 200 l RPMI, 10 ng/ml LPS, or 10 g/ml Pam3Cys. After 24 h,
supernatants were collected and stored at20°C until cytokine measure-
ment. Before restimulation, the supernatants were stored at 20°C for
lactate measurement.
For production of reactive oxygen species (ROS) and for cell counting
experiments, 5  106 monocytes were trained in vitro in 10-cm petri
dishes (Greiner) in 5-ml medium volumes for 24 h as described above
followed by a 6-day resting period. At day 6, cells were detached from the
plate with EDTA (Life Technologies) and counted. Cells (25,000 cells/
well) were restimulated as described above, and 100,000 cells/well were
used for ROS measurement, as described below.
Microscopy. Cell morphology was studied by conventional light mi-
croscopy during incubation each day. Before restimulation, pictures were
taken at4 and20 magnifications. Cell size was quantified using Leica
LAS EZ software (Leica Microsystems).
Reactive oxygen speciesmeasurements. Formeasurement of reactive
oxygen species production, a luminol-enhanced luminescence assay was
used. After detachment and counting of trainedmonocytes, a total of 1
105 cells were added per well of a white 96-well assay plate (Corning) in a
volume of 200 l. Cells were left either unstimulated or stimulated with
serum-opsonized zymosan at a concentration of 1 mg/ml. Luminol (145
g/ml) was added, and chemiluminescence was measured every 142 s for
1 h. All measurements were performed at least in duplicate, depending on
the number of cells available. Opsonized zymosan particles were prepared
by incubation of zymosan derived from Saccharomyces cerevisiae (Sigma-
Aldrich, St. Louis, MO, USA) in pooled human serum for 30min at 37°C,
after which the particles were washed twice in PBS and suspended in PBS.
Cytokine and lactate measurements. Cytokine production in super-
natants was determined using commercial enzyme-linked immunosor-
bent assay kits for tumor necrosis factor alpha (TNF-; R&D Systems,
MN, USA), interleukin-1 receptor antagonist (IL-1Ra; R&D Systems,
MN, USA), and IL-6 and IL-10 (Sanquin, Amsterdam, The Netherlands)
following the instructions of the manufacturers. The lactate concentra-
tion was measured using a lactate fluorometric assay kit (BioVision, CA,
USA).
Statistics. In vitro monocyte experiments were performed at least 6
times, and the results were analyzed using a Wilcoxon matched-pairs
signed-rank test comparing the fold change or raw cytokine values to the
values for the RPMI control. A two-sided P value below 0.05 was consid-
ered statistically significant. All data were analyzed using GraphPad Prism
software version 5.0 (La Jolla, CA, USA). Data are shown as means 
standard errors of the means.
RESULTS
Training induces an increase in proinflammatory cytokine pro-
duction, which is dependent on both training and resting time.As
FIG 1 Schematic overview of trained immunity methodology. Monocytes
were trained for 2 h (2 hr-T), 4 h (4 hr-T), or 24 h (24 hr-T). After the training
stimulus was washed away, the cells were rested for 24 h (24 h-R), 3 days
(3d-R), or 6 days (6d-R), after which the cells were restimulated with RPMI,
LPS, or Pam3Cys for 24 h.
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was shown previously, 24 h of incubation with -glucan, BCG, or
oxLDL induces a trained immune phenotype characterized by the
increased production of proinflammatory cytokines upon re-
stimulation at day 7 with heterologous stimuli. Here we aimed to
investigate how temporal changes in the duration of the first stim-
ulus and the timing of the second stimulus impact the develop-
ment of the trained immunity phenotype (Fig. 2A and B; see also
Fig. S2 in the supplemental material). Training with -glucan
induced the strongest increase in cytokine production upon
restimulation, whereas the effects of BCG and oxLDL were less
pronounced, although they were still associated with an approx-
imately 4- to 5-fold higher level of production of cytokines. For
-glucan and oxLDL training, the fold increases in the levels of
IL-6 andTNF- productionwere comparable, while primingwith
BCG led to a greater amplification of IL-6 (Fig. 2A) than TNF-
(Fig. 2B) production. For all three stimuli, priming for either 2 h,
4 h, or 24 h induced training, when the cells were rested for 3 or 6
days. However, the fold increase in cytokine productionwas high-
est with a 24-h training time interval.When comparing the differ-
ent time periods between stimulation and restimulation, it follows
that the trained phenotype developed only after at least 3 days,
with a maximum response occurring after 6 days.
Training-associated morphological changes. Upon training,
themonocytes not only changed their response to secondary stim-
uli and, subsequently, their cytokine production but also changed
their morphology. Just before restimulation, we analyzed cell
morphology and cell size by using light microscopy at two differ-
ent magnifications (Fig. 3A and B; see also Fig. S3 in the supple-
mentalmaterial).When cells were trained for 24 h and rested for 6
days, -glucan induced the most remarkable changes in cell mor-
phology: the cells were bigger than nontrained cells (32.5 m for
-glucan-trained cells versus 20.6 m for RPMI-trained cells).
BCGandoxLDL training induced onlyminor changes in cellmor-
phology, with a slight increase in cell size compared to that for the
untrained control cells being seen (29.2m for BCG-trained cells
and 26.5 m for oxLDL-trained cells). These morphological
FIG 2 Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. (A) IL-6 production after restimulation.
Cells were trained for 2 h, 4 h, or 24 h with -glucan, BCG, or oxLDL and rested for 24 h, 3 days (3d), or 6 days (6d). (B) TNF- production after restimulation.
Cells were trained for 2 h, 4 h, or 24 h with -glucan, BCG, or oxLDL and rested for 24 h, 3 days, or 6 days. Shown are the fold changes compared to the results
for the RPMI control (n 6; ^, P 0.06 compared to the RPMI control; *, P	 0.05 compared to the RPMI control; **, P	 0.01 compared to the RPMI control).
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changes persisted upon restimulation with LPS and Pam3Cys (see
Fig. S5).
We also analyzed cell numbers at the end of the most optimal
protocol of trained immunity induction (24 hof training, 6 days of
rest) by culturing cells in petri dishes, detaching them on day 6
before restimulation, and reseeding corrected cell numbers for
each condition. Counting experiments showed that -glucan
training induced a small increase in cell numbers on day 6 com-
pared to the cell numbers for the RPMI control (Fig. 3C), whereas
BCG or oxLDL training did not induce this increase in cell num-
bers. However, after correction for cell numbers, the level of cyto-
kine production upon restimulation was still significantly in-
creased, indicating that the increase in cytokine levels was not due
to an increased cell number but was mainly dependent on the
amount of cytokines produced by each cell (Fig. 3D).
The production of anti-inflammatory cytokines IL-10 and
IL-1Ra is increased in trained cells. Previously we have shown
that -glucan training increases not only proinflammatory cy-
tokine production but also anti-inflammatory cytokine pro-
duction (6). Therefore, wemeasured the levels of production of
two anti-inflammatory cytokines, IL-10 and IL-Ra, upon re-
stimulation for all three training stimuli and all training pro-
tocols. Training was associated with increased LPS-induced
IL-10 production, depending on the training time interval and
the resting time (Fig. 4A; see also Fig. S4A in the supplemental
material), but this reached statistical significance only for
training with -glucan. The production of IL-1Ra was in-
creased for all three training stimuli even without restimula-
tion (Fig. 4B), and this was dependent on the training duration
and the resting time (see Fig. S4B).
ROS production is increased upon BCG and oxLDL training
butnotupon-glucan training.To further characterize the func-
tional phenotype of trained monocytes, we measured another in-
nate immune effectormechanism, the oxidative burst, in themost
optimal protocol (24 h of training, 6 days of rest). Trained mono-
cytes were stimulated with opsonized zymosan since LPS was a
very poor inducer of the oxidative burst, and reactive oxygen spe-
cies inductionwith Pam3Cyswas very poor compared to that with
zymosan (21) (data not shown).
Cells trained with both BCG and oxLDL showed increased
production of ROS compared to the RPMI-treated control cells
when cells were stimulated with zymosan, although for oxLDL
FIG 3 Trained immunity effects on cell morphology and numbers. (A) Morphology of cells after 24 h of training and 6 days of rest when the cells were trained
with RPMI (negative control), -glucan, BCG, or oxLDL. Pictures were taken before restimulation at day 6. Magnification,20. (B) Size of cells after 24 h of
training and 6 days of rest before restimulation at day 6 (n 3, *, P	 0.05; compared to the RPMI control; ***, P	 0.001 compared to the RPMI control). (C)
Relative cell counts before restimulation at day 6 (n 6; *, P	 0.05, compared to the RPMI control; ns, not significant). (D) IL-6 and TNF- production after
restimulation for corrected cell counts (n 6; *, P	 0.05 compared to the RPMI control; **, P	 0.01 compared to the RPMI control).
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this effect was not statistically significant (Fig. 5). Interestingly,
cells trained with -glucan showed a very different pattern with
a slight but statistically significant downregulation of ROS pro-
duction (Fig. 5).
The metabolic switch toward the increased glycolysis in-
duced upon training is dependent on both training and resting
time. Previously, we have shown that trained immunity depends
on a metabolic shift from oxidative phosphorylation toward aer-
obic glycolysis (the Warburg effect) (22). Increased glycolysis re-
sults in increased lactate production by the cell, which can easily be
measured by analyzing the accumulation of lactate in the culture
medium. Before the cells were restimulated, the culture medium
was removed and stored and the lactate concentration was mea-
sured (Fig. 6). A 24-h resting time, independent of the training
time, did not increase glycolysis or lactate production. When cells
were rested for 3 days, lactate productionwas slightly increased for
cells trained with -glucan for 2 h and 24 h; for cells trained with
BCG, 2 h and 4 h of training induced a slight increase in glycolysis,
FIG 4 Anti-inflammatory cytokine production is increased in trained monocytes. (A) IL-10 production after restimulation. Cells were trained for 24 h with
-glucan, BCG, or oxLDL and rested for 6 days. The level of production of the anti-inflammatory cytokine IL-10 increased upon training. (B) IL-1Ra production.
Cells were trained for 24 hwith-glucan, BCG, or oxLDL and rested for 6 days. The level of production of the anti-inflammatory cytokine IL-1Ra increased upon
training not only after restimulation but also at the baseline (n 6; ^, P 0.06 compared to the RPMI control; *, P	 0.05 compared to the RPMI control; **,
P	 0.01 compared to the RPMI control; ns, not significant). P3C, Pam3Cys.
FIG 5 ROS production is a component of trained immunity for some stimuli.
The level of ROS productionwas significantly increased formonocytes trained
with BCG and oxLDL; training with -glucan decreased the level of ROS
production (n 6; *, P	 0.05 compared to the RPMI control; ***, P	 0.001
compared to the RPMI control; ns, not significant). Cells were trained for 24 h
using -glucan, BCG, or oxLDL, and normalized cell numbers were restimu-
lated using zymosan. Luminol was added, and luminescence wasmeasured for
1 h. RLU/s, relative light units per second.
Bekkering et al.
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while for cells trained with oxLDL, only a 4-h training period was
sufficient to induce a significant increase in lactate production.
When cells were rested for 6 days, however, all three training du-
rations induced a significant increase in lactate production for all
three stimuli. Interestingly, the level of lactate production and,
thus, glycolysis was increased even more with an increase in the
training duration.
DISCUSSION
In the present study, we describe the optimal conditions for the
induction of trained immunity in an in vitro model in primary
humanmonocytes. This model has previously been used to inves-
tigate several different stimuli, but the optimal parameters neces-
sary to induce trained immunity have not yet been characterized.
In this model, microbial or endogenous stimuli, such as-glucan,
BCG, and oxidized LDL, were added to monocytes for a short
period of time (training period), after which the cells were washed
and allowed to rest in culture medium, followed by restimulation
with unrelated antigens (6, 8, 11, 23, 24).
This study provides several new insights into this basic model
of trained innate immunity that will aid with the design of future
studies. First, induction of trained immunity depends on the du-
ration of the first stimulation time interval, the training period,
with an increase in the training time leading to the increased in-
duction of trained immunity, an effect which was observed for all
three stimuli. Second, the magnitude of the induction of nonre-
lated cytokine responses increases with the time that trained cells
are left to rest, most notably for -glucan-primed cells. The im-
portance of resting time for the establishment of trained immu-
nity has also recently been demonstrated in a study which de-
scribed the role of the transcription factor ATF7 in mediating the
epigenetic changes involved in innate immunememory, most no-
FIG 6 Trained immunity induction of glycolysis. Cells were trained for 2 h (2hr-T), 4 h (4hr-T), or 24 h (24hr-T) with RPMI (negative control),-glucan, BCG,
or oxLDL and rested for 24 h (24hr-R), 3 days (3d-R), or 6 days (6d-R). The level of lactate production in the supernatants was measured before restimulation
(n 6; *, P	 0.05 compared to the RPMI control; **, P	 0.01 compared to the RPMI control; ns, not significant).
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tably, those after LPS stimulation. At 3 days after the first LPS
challenge, the expression of TNF- andCxcl2 was decreased upon
rechallenge with LPS, whereas the opposite was true 3 weeks after
LPS challenge.Multiple proinflammatory genes were upregulated
at the later time point, and this upregulation was accompanied by
reduced amounts of epigenetic marks associated with gene silenc-
ing and the incomplete recruitment of ATF7, which was associ-
ated with the formation of heterochromatin. This study also
found that treatment with -glucan induced the phosphorylation
of ATF7, a finding analogous to that observed after treatment with
LPS (25). Similarly, our study showed the induction of tolerance,
most notably, with -glucan and BCG, when cells were only
briefly left to rest before rechallenge (24 h), whereas a training
effect was seen if cells were left to rest for 3 or 6 days. This could
suggest the intriguing possibility that ATF7 or analogous mecha-
nisms may be at play here. The importance of resting time in the
induction of trained immunity was also shown by the remarkable
increases in glycolysis in trained cells after 6 days of rest compared
to that after 1 day or 3 days of rest.
Another insight from this study is that trained immunity does
not only translate into an increased proinflammatory response of
monocytes but likely involves a more general increase in the re-
sponsiveness of the cells, as witnessed by the amplification of both
pro- and anti-inflammatory cytokine production, ROS produc-
tion (in the case of training with BCG and oxLDL), andmetabolic
activation. Of course, we should be cautious in the extrapolation
of all the details of the in vitro model to the in vivo situation: for
example, vaccination trials performed both in infants and in
adults showed increased proinflammatory cytokine responses af-
ter BCG vaccination, whereas no effects on anti-inflammatory
cytokine responses were noted (8, 24, 26). Furthermore, in pa-
tients suffering from elevated levels of lipoprotein(a), which in-
duces trained innate immunity in vitro, the anti-inflammatory
cytokine response was even decreased (17). In addition, it would
be most interesting to also assess the influence of trained immu-
nity on other important immunological effector mechanisms,
such as phagocytosis andmicrobial killing capacity.While thiswas
beyond the aims of the present study, such an investigation is
warranted for the future.
It is also important to note that different inducers of trained
immunity led to different phenotypic and functional changes, as
witnessed by light microscopy, cytokine production, and induc-
tion of ROS. Although a common denominator for the three
priming stimuli studied here was the upregulation of both pro-
and anti-inflammatory cytokine responses and the stimulation of
glycolysis, other physiological processes, such as induction of ROS
or cell proliferation, differed between different priming stimuli.
When cytokine responses were corrected for cell counts, the cyto-
kine responses were still strongly upregulated nevertheless. All in
all, however, these data suggest that each of these training stimuli
induces different trained immunity functional programs, and this
is not a surprise, considering their diverse nature (5).
In conclusion, although the effects of these three stimuli on
trained immunity have been described before, this is the first time
that the kinetics of this in vitro model have been studied. This
study describes the characteristics of an in vitro model for the
study of the influence of different stimuli on the induction of
trained innate immunity. This is a practical and useful method-
ological tool that will assist the research community with the in-
vestigation of this emerging field of immunology.
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Correction for Bekkering et al., “In Vitro
Experimental Model of Trained Innate
Immunity in Human Primary Monocytes”
Siroon Bekkering,a Bastiaan A. Blok,a,b,c Leo A. B. Joosten,a Niels P. Riksen,a
Reinout van Crevel,a Mihai G. Neteaa
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlandsa; Research
Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmarkb;
Odense Patient Data Explorative Network, University of Southern Denmark/Odense University Hospital,
Copenhagen, Denmarkc
Volume 23, no. 12, p. 926–933, 2016, https://doi.org/10.1128/CVI.00349-16. Page
927, column 1, line 37: “10 mM GlutaMAX, and 10 mM pyruvate” should read “2 mM
GlutaMAX, and 1 mM pyruvate.”
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